Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Down-Regulation of Na+/K+ATPase Activity by Human Parvovirus B19 Capsid Protein VP1
2013 Standout
Arrhythmias in adult congenital heart disease
2006
Patent Ductus Arteriosus: Catheter Closure in the Adult Patient
2001
Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation
2017 Standout
A strategic approach to transcatheter closure of patent ductus: Gianturco coils for small-to-moderate ductus and Amplatzer duct occluder for large ductus
2005
Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension
1998
Meta-Analysis of Transcatheter Closure Versus Medical Therapy for Patent Foramen Ovale in Prevention of Recurrent Neurological Events After Presumed Paradoxical Embolism
2012
Multicenter USA Amplatzer Patent Ductus Arteriosus Occlusion Device Trial
2004
Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism
2013 Standout
Treatment of Pulmonary Arterial Hypertension
2004 Standout
Causes of Recurrent Focal Neurologic Events After Transcatheter Closure of Patent Foramen Ovale With the CardioSEAL Septal Occluder
2008
Percutaneous Interventions on Severe Coarctation of the Aorta: A 21-Year Experience
2005
PERCUTANEOUS TRANSCATHETER CLOSURE OF PATENT DUCTUS ARTERIOSUS WITH AN AMPLATZER DUCT OCCLUDER USING RETROGRADE GUIDEWIRE‐ESTABLISHED FEMORAL ARTERIOVENOUS LOOP
2007
Transcatheter closure of patent ductus arteriosus with severe pulmonary arterial hypertension in adults
2006
Successful repositioning of an Amplatzer duct occluder immediately after inadvertent embolization in the descending aorta
2003
Embolic strokes of undetermined source: the case for a new clinical construct
2014 Standout
Transcatheter Closure of a Large Patent Ductus Arteriosus in a Young Child Using the Amplatzer Duct Occluder
2005
The efficacy and safety of the Amplatzer ductal occluder in young children and infants
2005
The right ventricle in congenital heart disease
2006
Zebrafish TRPA1 Channels Are Required for Chemosensation But Not for Thermosensation or Mechanosensory Hair Cell Function
2008 StandoutNobel
Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis
2007 Nature
Comparison of transcatheter closure of secundum atrial septal defect using the Amplatzer septal occluder associated with deficient versus sufficient rims
2002
Hematopoiesis: An Evolving Paradigm for Stem Cell Biology
2008 Standout
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
The Amplatzer septal occluder
2000
Retrograde use of the Cardioseal/Starflex occluder device
2005
Early clinical experience with the new amplatzer ductal occluder II for closure of the persistent arterial duct
2009
Atrial septostomy as a bridge to lung transplantation in patients with severe pulmonary hypertension
1999
Transcatheter closure of persistent ductus arteriosus in infants using the Amplatzer duct occluder
2001
Results and mid–long-term follow-up of stent implantation for native and recurrent coarctation of the aorta
2005
Left ventricular remodeling and change of systolic function after closure of patent ductus arteriosus in adults: Device and surgical closure
2007
Long-term outcome of transcatheter patent ductus arteriosus closure using Amplatzer duct occluders
2006
Transcatheter closure of congenital ventricular septal defects: results of the European Registry
2007
Transcatheter closure of Fontan fenestrations using the Amplatzer septal occluder: Initial experience and follow-up
2000
Periventricular closure of ventricular septal defects without cardiopulmonary bypass
1999
Transcatheter Atrial Septal Defect Closure Assisted by Intracardiac Echocardiography: 3‐Year Follow‐Up
2004
Transthoracic echocardiographic guidance of transcatheter atrial septal defect closure
2004
Retrograde wire‐assisted percutaneous transcatheter closure of persistent ductus arteriosus with Amplatzer duct occluder in the elderly: A new application
2004
Acute and intermediate outcomes, and evaluation of injury to the aortic wall, as based on 15 years experience of implanting stents to treat aortic coarctation
2007
Amplatzer®Duct Occluder device: a new technology for the closure of the moderate-to-large-sized patent ductus arteriosus
2006
Transcatheter occlusion of patent ductus arteriosus using a new angled Amplatzer duct occluder: Initial clinical experience
2003
Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder
2004
Sustained risk of recurrent thromboembolic events in patients with patent foramen ovale and paradoxical embolism: long-term follow-up over more than 15 years
2011
Eicosanoids and cancer
2010 Standout
Technical Report: Diagnosis and Management of Childhood Obstructive Sleep Apnea Syndrome
2002
The Results of Catheter-Based Therapy Compared With Surgical Repair of Adult Aortic Coarctation
2006
Transcatheter closure of perimembranous ventricular septal defects using the amplatzer membranous VSD occluder: Immediate and midterm results of an international registry
2006
Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults
2002
Novel use of a modified Amplatzer Vascular Plug® to occlude a patent ductus arteriosus in two patients
2008
Choice of Device Size and Results of Transcatheter Closure of Atrial Septal Defect Using the Amplatzer Septal Occluder
2002
Topological design and additive manufacturing of porous metals for bone scaffolds and orthopaedic implants: A review
2016 Standout
Molecular pathology of inflammatory cardiomyopathy
2004
Down syndrome
2020 Standout
22q11.2 deletion syndrome
2015 Standout
Device closure of muscular ventricular septal defects in infants less than one year of age using the Amplatzer devices: Feasibility and outcome
2007
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Transcatheter closure of coronary artery fistulae using the Amplatzer duct occluder
2006
Experience with transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder: a single centre study in 236 consecutive patients
2003
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
1998 Standout
Device closure of ventricular septal defects
2003
Smart Materials Applications for Pediatric Cardiovascular Devices
2008
Changing Mortality in Congenital Heart Disease
2010 Standout
Transcatheter closure of moderate to large patent ductus arteriosus with the Amplatzer duct occluder
2007
Development of new metallic alloys for biomedical applications
2012 Standout
Mid-term effects of implanting stents for relief of aortic recoarctation on systemic hypertension, carotid mechanical properties, intimal medial thickness and reflection of the pulse wave
2005
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Recurrent cerebral ischemia in medically treated patent foramen ovale
2009
A review of shape memory alloy research, applications and opportunities
2013 Standout
Transcatheter occlusion of moderate to large patent arterial ducts, having a diameter above 2.5 mm, with the Amplatzer Duct Occluder. Comparisons with the Rashkind, buttoned devices, and coils in 116 consecutive patients
2003
Clinical Outcome of Fenestrated Fontan Patients After Closure
2000
Hygromorphic materials for sustainable responsive architecture
2015 Standout
Transcatheter Device Closure of Congenital and Postoperative Residual Ventricular Septal Defects
2004
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
2008 Standout
An overview of nitinol medical applications
1999 Standout
Stimulus-responsive shape memory materials: A review
2011
Diagnosis and Management of Childhood Obstructive Sleep Apnea Syndrome
2012 Standout
Biomedical Applications of Shape Memory Alloys
2011
Transcatheter closure of atrial septal defect and interatrial communications with a new self expanding nitinol double disc device (Amplatzer septal occluder): multicentre UK experience
1999
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Indications for Cardiac Catheterization and Intervention in Pediatric Cardiac Disease
2011 Standout
Congenital heart disease and cardiac procedural outcomes in patients with trisomy 21 and Turner syndrome
2017
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
2008
Long-term results after balloon pulmonary valvuloplasty.
1991
Prevention and Treatment of Thrombosis in Pediatric and Congenital Heart Disease
2013
Biodegradable metals
2014 Standout
Patent Foramen Ovale Closure and Medical Treatments for Secondary Stroke Prevention
2011
Experimental atrial septal defect closure with a new, transcatheter, self-centering device.
1993
Pediatric Therapeutic Cardiac Catheterization
1998
Pharyngeal Hypoplasia in Treacher Collins Syndrome
1979
Improvement of damping properties in laser processed superelastic Cu-Al-Mn shape memory alloys
2016 Standout
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
Difficult tracheal intubation: a retrospective study
1987 Standout
Prognosis of Cryptogenic Stroke With Patent Foramen Ovale at Older Ages and Implications for Trials
2020
Soft Robotic Grippers
2018 Standout
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
Metallic implant biomaterials
2014 Standout
Developmental Changes in Prostaglandin E2Receptor Subtypes in Porcine Ductus Arteriosus
1999
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2
2001 StandoutNobel
A novel approach to temporary stenting: degradable cardiovascular stents produced from corrodible metal—results 6–18 months after implantation into New Zealand white rabbits
2001
Transcatheter closure of large sized patent ductus arteriosus using the amplatzer duct occluder device.
2009
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
Iron-based shape memory alloy strips for strengthening RC members: Material behavior and characterization
2018 Standout
Neurodevelopmental Outcomes in Children With Congenital Heart Disease: Evaluation and Management
2012 Standout
Diagnosis and Management of Childhood Obstructive Sleep Apnea Syndrome
2012 Standout
Works of Basil D. Thanopoulos being referenced
Patent Ductus Arteriosus Equipment and Technique. Amplatzer Duct Occluder: Intermediate‐Term Follow‐Up and Technical Considerations
2001
Usefulness of Stenting in Aortic Coarctation in Patients With the Turner Syndrome
2010
Transcatheter closure of perimembranous ventricular septal defects with the Amplatzer asymmetric ventricular septal defect occluder: preliminary experience in children
2003
Transcatheter closure of high pulmonary artery pressure persistent ductus arteriosus with the Amplatzer muscular ventricular septal defect occluder
2002
Catheter Closure of Congenital/Acquired Muscular VSDs and Perimembranous VSDs Using the Amplatzer Devices
2003
Transcatheter Closure of Perimembranous Ventricular Septal Defects in Infants and Children Using the Amplatzer Perimembranous Ventricular Septal Defect Occluder
2007
Closure of Atrial Septal Defects With the Amplatzer Occlusion Device: Preliminary Results
1998
Comparison and Results of Transcatheter Closure of Patent Ductus Arteriosus Using the Swivel-Disk Device Versus Plug Occluder in Children
2008
Further experience with transcatheter closure of the patent ductus arteriosus using the Amplatzer duct occluder
2000
Transcatheter closure of the patent ductus arteriosus using the new Amplatzer duct occluder
2008
Valvuloplasty with Large Trefoil Balloons for the Treatment of Congenital Pulmonary Stenosis
1989
Initial human experience with the Amplatzer perimembranous ventricular septal occluder device
2003
Transvenous atrial septal defect occlusion by the buttoned device
1990
Transcatheter closure of muscular ventricular septal defects with the amplatzer ventricular septal defect occluder: initial clinical applications in children11The Amplatzer VSD occluders were provided by AGA, Medical Corporation, Golden Valley, Minnesota. There were no sources of financial support.
1999
Cardiac Involvement in Postnatal Rubella
1989
Outcome of transcatheter closure of muscular ventricular septal defects with the Amplatzer ventricular septal defect occluder
2005
Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke
2006
Stent treatment for coarctation of the aorta: intermediate term follow up and technical considerations
2000
Prostaglandin E2 administration in infants with ductus-dependent cyanotic congenital heart disease
1987
CARDIORESPIRATORY SYNDROME DUE TO ENLARGED TONSILS AND ADENOIDS
1975
Severe hemolysis complicating transcatheter occlusion of a patent ductus arteriosus: the importance of elimination of residual flow.
2008
Percutaneous balloon dilatation of the atrial septum: immediate and midterm results.
1996
Transcatheter closure of atrial septal defects in adults with the Amplatzer septal occluder
1999